Similar articles

• Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.

  Saller CF, Stricker EM. Saller CF, et al. Neuropharmacology. 1978 Jul;17(7):499-506. doi: 10.1016/0028-3908(78)90056-4. Neuropharmacology. 1978. PMID: 692815 No abstract available.
• Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.

  Nelson DL, Herbet A, Bourgoin S, Glowinski J, Hamon M. Nelson DL, et al. Mol Pharmacol. 1978 Nov;14(6):983-95. Mol Pharmacol. 1978. PMID: 732817 No abstract available.
• Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.

  Sievers J, Baumgarten HG, Klemm HP, Schlossberger HG, Lolova I. Sievers J, et al. Bibl Anat. 1981;(19):302-7. Bibl Anat. 1981. PMID: 7225075 No abstract available.
• Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.

  Hrdina PD, Pappas BA, Bialik RJ, Ryan CL. Hrdina PD, et al. Eur J Pharmacol. 1982 Sep 24;83(3-4):343-4. doi: 10.1016/0014-2999(82)90275-8. Eur J Pharmacol. 1982. PMID: 7173315 No abstract available.
• Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.

  Mackenzie RG, Hoebel BG, Norelli HC, Trulson ME. Mackenzie RG, et al. Neuropharmacology. 1978 Nov;17(11):957-63. doi: 10.1016/0028-3908(78)90138-7. Neuropharmacology. 1978. PMID: 152872 No abstract available.